First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

521 Reviews

Credit Rating - AVICENNA MEDICAL LIMITED

ANALYSIS
Credit Risk Update: AVICENNA MEDICAL LIMITED, 44 GRASMERE AVENUE, WIMBLEDON, LONDON, SW19 3DX. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 March 2023. The company was incorporated on 20 August 2008.

The accounts next due date is 31 December 2024. There are no mortgages.

The above was based on public record information as at 23 April 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 06677611
Date Incorporated: 20 August 2008
Date Latest Accounts: 31 March 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 06677611
Annual Return: 20 August 2015
Registered Office: 44 GRASMERE AVENUE, WIMBLEDON, LONDON, SW19 3DX
SIC Code and Operations: 85422,86210
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

AVICENNA MEDICAL LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 3 May 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09196029 AVICENNA MEDICAL MANCHESTER LTD Dissolved
09807783 AVICENNA MEDICAL SERVICES AMS LTD Active - Proposal to Strike off
09493327 AVICENNA MEDICAL SERVICES LTD Active - Proposal to Strike off
09400577 AVICENNA MEDICAL SOLUTIONS LTD Dissolved
07049000 AVICENNA MEDICAL TECHNOLOGIES LIMITED Dissolved

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd